Skip to content
Translational Neuropharmacology Lab (Zanos Lab)

Translational Neuropharmacology Lab (Zanos Lab)

Our laboratory, based in Cyprus, employs molecular and systems neuroscience, behavioral pharmacology, as well as advanced computational methods to unravel the mysteries of brain diseases and identify targets for the development of novel and effective pharmacotherapies.

Menu
  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Author: admin

New Publication in Neuroscience & Biobehavioral Reviews: A Hierarchical Framework for Nociplastic Pain

No Comments
| News

We are pleased to share our latest work, published in Neuroscience & Biobehavioral Reviews, which presents a novel multilevel framework for nociplastic pain. Nociplastic pain, which arises from altered pain processing rather than clear tissue or nerve damage, remains one of the most challenging forms of chronic pain to understand and treat. This work is […]

Read More »

Dr. Charalambous presents brain aging research at AAIC 2026

No Comments
| News

We are delighted to share that Dr. Eleftheria G. Charalambous, member of the AI & Systems Bioinformatics Unit (Cyprus), led by Dr. Anna Onisiforou, presented our findings at the Alzheimer’s Association International Conference (AAIC) 2026, held 12-15 July in London, United Kingdom. AAIC is the world’s largest meeting dedicated to advancing Alzheimer’s disease and dementia […]

Read More »

Mapping the Epstein-Barr Virus-Multiple Sclerosis Axis: Dr. Anna Onisiforou presents VirTrack and VirTarget at the FENS Forum 2026

No Comments
| News

Dr. Anna Onisiforou, Head of the AI and Systems Bioinformatics Unit at our lab, presented her work at the FENS Forum 2026, Europe’s largest neuroscience congress, held on 6–10 July 2026 in Barcelona, Spain. Her poster, “Unmasking the Role of Epstein–Barr Virus in Multiple Sclerosis: Clinical-Type Specific Pathogenesis and Virus-Informed Comparative Analysis of Immunotherapies,” was […]

Read More »

Dr. Panoutsopoulos presents research on ketamine and early neurodevelopment at FENS Forum 2026

No Comments
| News

We are proud to share that Dr. Alexios Panoutsopoulos, postdoctoral researcher in the Zanos Lab, presented his work at the FENS Forum 2026, held 6-10 July in Barcelona, Spain. The FENS Forum is Europe’s largest neuroscience meeting, and this year’s edition was the biggest yet, drawing more than 8,000 attendees from across the world. The […]

Read More »

Research spotlight: Unraveling the role of Eukaryotic Elongation Factor 2 Kinase in the antidepressant mechanism of (2R,6R)-hydroxynorketamine

No Comments
| News

We are proud to share that our Ph.D., Mr. Morfeas Koumas, recently presented his research as a poster at 2026 Department of Psychology Academic Conference at the University of Cyprus, showcasing work conducted as part of the EloKet project of our lab. His study, titled “Unraveling the Role of Eukaryotic Elongation Factor 2 Kinase in […]

Read More »

Research spotlight: Alexithymia and emotion regulation across smoking status groups

No Comments
| News

We are proud to share that our research assistant, Ms. Styliani Kaimakkami, recently presented her research poster at the 2026 Department of Psychology Academic Conference at the University of Cyprus, showcasing work conducted as part of the BioNic project of our lab. Her study, titled “Smoking Away Emotions: Alexithymia and Emotion Regulation Across Smoking Status […]

Read More »

New manuscript: The Immunosuppression Paradox in Multiple Sclerosis: Are We Fueling the Fire by Suppressing Immunity in an Epstein–Barr Virus–Linked Disease?

No Comments
| News

We are excited to announce a new publication by Dr. Anna Onisiforou, head of our AI and Systems Bioinformatics Unit Cyprus, published in Open Forum Infectious Diseases. This review paper, titled “The Immunosuppression Paradox in Multiple Sclerosis: Are We Fueling the Fire by Suppressing Immunity in an Epstein–Barr Virus–Linked Disease?”, raises a fundamental question about […]

Read More »

New Preprint article – From Heatwaves to Brainwaves: Climate-Driven Microplastics Promote Epstein–Barr Virus Reactivation and Female-Biased Risk for Alzheimer’s Disease and Multiple Sclerosis

No Comments
| News

Climate change accelerates the breakdown of plastics, increasing our exposure to microplastic-derived compounds, including bisphenols and phthalates, that act as xenoestrogens capable of disrupting hormonal and immune regulation. Separately, Epstein–Barr virus (EBV), which infects over 95% of adults worldwide and persists silently in immune cells, has been increasingly implicated in the development of both Alzheimer’s […]

Read More »

New Publication – Linking Misophonia and Tinnitus: Common and Divergent Neurobiological Mechanisms

No Comments
| News

We are excited to share our new publication in Neuroscience and Biobehavioral Reviews. This is the first review to systematically compare the neurobiological underpinnings of misophonia and tinnitus. These are two debilitating auditory conditions that exact a significant toll on social functioning and mental health. Although often studied in isolation, both disorders share striking neurobiological […]

Read More »

Dr. Zanos Appointed to the Editorial Board of the Neuropharmacology Journal

No Comments
| News

We are pleased to announce that Dr. Zanos, Director of the Translational Neuropharmacology Lab, has been appointed as an Editorial Board Member of Neuropharmacology, one of the leading journals in the field of neuroscience and pharmacology. Neuropharmacology, published by Elsevier, is a premier international journal that publishes high-impact research on the effects of drugs on […]

Read More »

Posts pagination

1 2 … 12 Next

Recent Posts

  • New Publication in Neuroscience & Biobehavioral Reviews: A Hierarchical Framework for Nociplastic Pain September 11, 2026
  • Dr. Charalambous presents brain aging research at AAIC 2026 July 13, 2026
  • Mapping the Epstein-Barr Virus-Multiple Sclerosis Axis: Dr. Anna Onisiforou presents VirTrack and VirTarget at the FENS Forum 2026 July 9, 2026
  • Dr. Panoutsopoulos presents research on ketamine and early neurodevelopment at FENS Forum 2026 July 8, 2026
  • Research spotlight: Unraveling the role of Eukaryotic Elongation Factor 2 Kinase in the antidepressant mechanism of (2R,6R)-hydroxynorketamine June 4, 2026

Navigation

  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Translational Neuropharmacology Lab (Zanos Lab) 2026 . Powered by WordPress